Aflibercept a 'Powerful' Tool in Treatment of Diabetic Macular Edema: Charles Wykoff, Retina Consultants Houston

Video

The treatment of diabetic retinopathy, particularly diabetic macular edema has come a long way over the past decade, especially since the approval of aflibrecept to treat these patients.

The treatment of diabetic retinopathy, particularly diabetic macular edema has come a long way over the past decade, especially since the approval of aflibercept to treat these patients.

Charles C. Wykoff, MD, PhD, from Retina Consultants Houstan, discussed this topic during the annual meeting of the American Academy of Ophthalmology in Chicago. Wykoff said because of the damage diabetes can do to a patient's eyes treating it correctly can make a considerable difference in the life of a patient.

Related Videos
Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy| Image Credit: University of Chicago
Why Are Adult ADHD Cases Climbing?
Deepak Sambhara, MD | Image Credit: American Society of Retina Specialists
How Psoriatic Arthritis Presentation, Treatment Has Evolved
Optimizing Diabetes Therapies with New Classifications
Anthony Lembo, MD | Credit: Cleveland Clinic
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Prashant Singh, MD | Credit: University of Michigan
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME | Image Credit: Linkedin
© 2024 MJH Life Sciences

All rights reserved.